Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 11Prostatic Neoplasms 10Breast Neoplasms 8Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lung Neoplasms 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Thrombocythemia, Essential 2Testicular Neoplasms 2Stomach Neoplasms 2Skin Diseases 2Primary Myelofibrosis 2Polycythemia Vera 2Myeloproliferative Disorders 2Melanoma 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Hodgkin Disease 2Hematologic Diseases 2Glioma 2Burkitt Lymphoma 2Breast Neoplasms, Male 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1

Interventions

Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Hemangiopericytoma × Watchful Waiting × Clear all
NCT05259605 2025-12-17

Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification

European Organisation for Research and Treatment of Cancer - EORTC

Recruiting
1,650 enrolled
CNS

Ependymoma, Glioma, Hemangiopericytoma, Neoplasms, Germ Cell and Embryonal, Pinealoma, Choroid Plexus Neoplasms, Hemangioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡